Coronavirus Disease 2019-associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?
作者信息
Baddley John W
机构信息
University of Maryland School of Medicine and Baltimore VA Medical Center, Baltimore, Maryland, USA.
出版信息
Clin Infect Dis. 2022 Jan 7;74(1):92-94. doi: 10.1093/cid/ciab259.
Abstract
摘要
相似文献
1
Coronavirus Disease 2019-associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?
Clin Infect Dis. 2022 Jan 7;74(1):92-94. doi: 10.1093/cid/ciab259.
2
Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis.
Emerg Infect Dis. 2021 Nov;27(11):2892-2898. doi: 10.3201/eid2711.211174. Epub 2021 Sep 14.
3
Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
Rev Esp Anestesiol Reanim (Engl Ed). 2022 Jan;69(1):48-53. doi: 10.1016/j.redare.2021.02.007. Epub 2022 Jan 7.
4
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
Infection. 2022 Feb;50(1):43-56. doi: 10.1007/s15010-021-01701-x. Epub 2021 Sep 27.
5
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
Intensive Care Med. 2021 Aug;47(8):819-834. doi: 10.1007/s00134-021-06449-4. Epub 2021 Jun 23.
6
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. doi: 10.1093/cid/ciaa1065.
7
COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
J Infect Public Health. 2022 Feb;15(2):222-227. doi: 10.1016/j.jiph.2021.12.015. Epub 2022 Jan 6.
8
Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
Clin Infect Dis. 2022 Jan 7;74(1):83-91. doi: 10.1093/cid/ciab223.
9
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).
Med Mycol. 2021 Jan 4;59(1):110-114. doi: 10.1093/mmy/myaa078.
10
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
J Korean Med Sci. 2022 May 9;37(18):e134. doi: 10.3346/jkms.2022.37.e134.
引用本文的文献
1
A 67-Year-Old Man with a History of COVID-19 Infection, Cough, and Hemoptysis.
Tanaffos. 2024 Jan;23(1):97-99.
2
Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis.
Heliyon. 2023 Oct 26;9(11):e21721. doi: 10.1016/j.heliyon.2023.e21721. eCollection 2023 Nov.
3
The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan.
Bosn J Basic Med Sci. 2022 Sep 16;22(5):784-790. doi: 10.17305/bjbms.2022.7335.
4
When Viruses Meet Fungi: Tackling the Enemies in Hematology.
J Fungi (Basel). 2022 Feb 13;8(2):184. doi: 10.3390/jof8020184.
5
Detection of in Patients with Severe COVID-19: Diagnostic and Therapeutic Challenges.
J Fungi (Basel). 2021 Jul 22;7(8):585. doi: 10.3390/jof7080585.
Zotero 插件